1. Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Biros, D.; Papathanasiou, A.; Papagiannopoulos, C.; Klouras, E.; Athanasiou, L.; Tsourlos, S.; Filippas-Ntekouan, S.; Samanidou, V.; Kolios, N.-G.; Veliani, C.; Pappa, C.; Zarachi, A.; Christaki, E.; Liberopoulos, E.; Elisaf, M.; Milionis, H.; Liamis, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Filippas-Ntekouan, S.; Biros, D.; Kolios, N.-G.; Veliani, C.; Papagiannopoulos, C.; Samanidou, V.; Papathanasiou, A.; Tsourlos, S.; Athanasiou, L.; Pappa, C.; Pargana, E.; Nasiou, M.; Zarachi, A.; Tsiakas, I.; Christaki, E.; Elisaf, M.; Liberopoulos, E.; Milionis, H.; Liamis, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative effect of delapril-manidipine treatment versus valsartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Biros, D.; Papathanasiou, A.; Papagiannopoulos, C.; Klouras, E.; Tsourlos, S.; Athanasiou, L.; Filippas-Ntekouan, S.; Kolios, N.-G.; Veliani, C.; Pappa, C.; Zarachi, A.; Samanidou, V.; Christaki, E.; Christaki, M.; Vagias, I.; Liberopoulos, E.; Elisaf, M.; Milionis, H.; Liamis, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative effect of delapril-manidipine treatment versus valsartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Filippas-Ntekouan, S.; Biros, D.; Papathanasiou, A.; Papagiannopoulos, C.; Kolios, N.-G.; Veliani, C.; Athanasiou, L.; Samanidou, V.; Tsourlos, S.; Pappa, C.; Pargana, E.; Nasiou, M.; Zarachi, A.; Christaki, E.; Elisaf, M.; Liberopoulos, E.; Milionis, H.; Liamis, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Biros, D.; Papathanasiou, A.; Papagiannopoulos, C.; Klouras, E.; Tsourlos, S.; Athanasiou, L.; Filippas-Ntekouan, S.; Zarachi, A.; Kolios, N.-G.; Pappa, C.; Samanidou, V.; Christaki, E.; Liberopoulos, E.; Elisaf, M.; Milionis, H.; Liamis, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Filippas-Ntekouan, S.; Biros, D.; Kolios, N.-G.; Papagiannopoulos, C.; Veliani, C.; Papathanasiou, A.; Samanidou, V.; Tsourlos, S.; Athanasiou, L.; Pappa, C.; Pargana, E.; Nasiou, M.; Zarachi, A.; Vagias, I.; Tsiakas, I.; Christaki, E.; Elisaf, M.; Liberopoulos, E.; Milionis, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Laboratory findings and clinical outcomes of 681 COVID-19 patients with dyslipidemia requiring hospitalization. (August 2022) Authors: Liontos, A.; Biros, D.; Milionis, O.; Tsourlos, S.; Athanasiou, L.; Papathanasiou, A.; Kolios, N.-G.; Pappa, C.; Veliani, C.; Samanidou, V.; Siopis, G.; Pargana, E.; Nasiou, M.; Armata, N.-N.; Anagnostopoulos, S.-P.; Poulopoulou, A.; Filippas-Ntekouan, S.; Christaki, M.; Rapti, I.; Panteli, A. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Managing the patient with haemoglobinopathy and multiple red cell antibodies. (29th January 2016) Authors: Politis, C.; Hassapopoulou, E.; Halkia, P.; Kourakli, A.; Mougiou, A.; Zervou, E.; Kleronomos, E.; Sfyridaki, K.; Pappa, C.; Tsoumari, I.; Lafiatis, I.; Kavallierou, L.; Parara, M.; Richardson, C. Journal: ISBT science series Issue: Volume 11(2016)Supplement 1 Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study. (May 2021) Authors: Gkrozou, F.; Pappa, C.; Tsonis, O.; Dimitriou, E.; Paschopoulos, M. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 260(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The possible role of TyG index and TRG/HDL, CRP/HDL, NEUTROPHILS/HDL lymphocytes/HDL ratios in disease severity and outcomes in COVID-19 hospitalized patients with arterial hypertension. (August 2022) Authors: Liontos, A.; Biros, D.; Papathanasiou, A.; Milionis, O.; Nasiou, M.; Pargana, E.; Kolios, N.-G.; Pappa, C.; Tsourlos, S.; Athanasiou, L.; Siopis, G.; Zarachi, A.; Tsarapatsani, K.; Samanidou, V.; Konstantopoulou, R.; Tsiakas, I.; Filippas-Ntekouan, S.; Vagias, I.; Christaki, E.; Liberopoulos, E. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗